Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Operating Expenses (2016 - 2026)

Pharma-Bio Serv's Operating Expenses history spans 16 years, with the latest figure at $816909.0 for Q1 2026.

  • For Q1 2026, Operating Expenses fell 5.04% year-over-year to $816909.0; the TTM value through Jan 2026 reached $3.5 million, down 5.03%, while the annual FY2025 figure was $3.5 million, 6.73% down from the prior year.
  • Operating Expenses reached $816909.0 in Q1 2026 per PBSV's latest filing, down from $882207.0 in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $1.1 million in Q3 2023 to a low of $816909.0 in Q1 2026.
  • Average Operating Expenses over 5 years is $930807.7, with a median of $931850.0 recorded in 2024.
  • Peak YoY movement for Operating Expenses: plummeted 85.08% in 2022, then rose 15.56% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $939683.0 in 2022, then rose by 4.46% to $981570.0 in 2023, then dropped by 10.28% to $880700.0 in 2024, then grew by 0.17% to $882207.0 in 2025, then fell by 7.4% to $816909.0 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Operating Expenses are $816909.0 (Q1 2026), $882207.0 (Q4 2025), and $888139.0 (Q3 2025).